DaVita Inc. (0I7E.L)
USD 140.66
(-2.32%)
USD 140.66
(-2.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.47 Billion USD | -29.4% |
| 2022 | 2.08 Billion USD | 11.29% |
| 2021 | 1.87 Billion USD | -0.11% |
| 2020 | 1.87 Billion USD | 9.28% |
| 2019 | 1.71 Billion USD | -0.04% |
| 2018 | 1.71 Billion USD | 6.33% |
| 2017 | 1.61 Billion USD | -30.44% |
| 2016 | 2.32 Billion USD | -10.4% |
| 2015 | 2.59 Billion USD | 37.71% |
| 2014 | 1.88 Billion USD | -10.59% |
| 2013 | 2.1 Billion USD | 58.82% |
| 2012 | 1.32 Billion USD | 38.72% |
| 2011 | 956.42 Million USD | -1.97% |
| 2010 | 975.62 Million USD | 6.06% |
| 2009 | 919.86 Million USD | 0.21% |
| 2008 | 917.92 Million USD | 13.1% |
| 2007 | 811.59 Million USD | 8.09% |
| 2006 | 750.87 Million USD | 58.65% |
| 2005 | 473.3 Million USD | 41.96% |
| 2004 | 333.4 Million USD | 8.48% |
| 2003 | 307.32 Million USD | 25.13% |
| 2002 | 245.61 Million USD | 5.82% |
| 2001 | 232.1 Million USD | -15.56% |
| 2000 | 274.87 Million USD | -26.95% |
| 1999 | 376.28 Million USD | 77.33% |
| 1998 | 212.2 Million USD | 222.49% |
| 1997 | 65.8 Million USD | 63.68% |
| 1996 | 40.2 Million USD | 191.3% |
| 1995 | 13.8 Million USD | -14.81% |
| 1994 | 16.2 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 549.56 Million USD | 36.89% |
| 2024 Q3 | 580.54 Million USD | 56.82% |
| 2024 Q2 | 367.84 Million USD | -33.07% |
| 2023 Q1 | 509.68 Million USD | -11.17% |
| 2023 Q3 | 565.3 Million USD | 3.22% |
| 2023 Q4 | 401.47 Million USD | -28.98% |
| 2023 FY | 1.47 Billion USD | -29.4% |
| 2023 Q2 | 547.68 Million USD | 7.46% |
| 2022 Q2 | 486.39 Million USD | 3.98% |
| 2022 Q1 | 467.76 Million USD | -5.97% |
| 2022 FY | 2.08 Billion USD | 11.29% |
| 2022 Q3 | 559.86 Million USD | 15.1% |
| 2022 Q4 | 573.77 Million USD | 2.49% |
| 2021 Q2 | 467.78 Million USD | 4.62% |
| 2021 Q1 | 447.12 Million USD | -4.05% |
| 2021 Q3 | 463.55 Million USD | -0.9% |
| 2021 Q4 | 497.48 Million USD | 7.32% |
| 2021 FY | 1.87 Billion USD | -0.11% |
| 2020 Q3 | 520.17 Million USD | 9.84% |
| 2020 FY | 1.87 Billion USD | 9.28% |
| 2020 Q2 | 473.58 Million USD | 13.23% |
| 2020 Q1 | 418.25 Million USD | -4.27% |
| 2020 Q4 | 466 Million USD | -10.41% |
| 2019 FY | 1.71 Billion USD | -0.04% |
| 2019 Q2 | 427.58 Million USD | 7.07% |
| 2019 Q4 | 436.89 Million USD | -3.91% |
| 2019 Q1 | 399.34 Million USD | -5.75% |
| 2019 Q3 | 454.65 Million USD | 6.33% |
| 2018 Q1 | 403.32 Million USD | -0.2% |
| 2018 Q4 | 423.68 Million USD | -12.3% |
| 2018 Q2 | 409.07 Million USD | 1.42% |
| 2018 Q3 | 483.09 Million USD | 18.1% |
| 2018 FY | 1.71 Billion USD | 6.33% |
| 2017 Q4 | 404.13 Million USD | -32.71% |
| 2017 Q3 | 600.61 Million USD | 3.24% |
| 2017 FY | 1.61 Billion USD | -30.44% |
| 2017 Q1 | 583.89 Million USD | -3.18% |
| 2017 Q2 | 581.74 Million USD | -0.37% |
| 2016 Q1 | 558.3 Million USD | -2.9% |
| 2016 Q4 | 603.08 Million USD | 1.8% |
| 2016 Q3 | 592.4 Million USD | 3.78% |
| 2016 FY | 2.32 Billion USD | -10.4% |
| 2016 Q2 | 570.84 Million USD | 2.25% |
| 2015 Q3 | 518.06 Million USD | 0.98% |
| 2015 Q2 | 513.02 Million USD | -48.31% |
| 2015 Q1 | 992.41 Million USD | 93.07% |
| 2015 FY | 2.59 Billion USD | 37.71% |
| 2015 Q4 | 574.95 Million USD | 10.98% |
| 2014 Q3 | 492.97 Million USD | 10.1% |
| 2014 Q1 | 429.15 Million USD | -6.61% |
| 2014 Q4 | 514.01 Million USD | 4.27% |
| 2014 FY | 1.88 Billion USD | -10.59% |
| 2014 Q2 | 447.75 Million USD | 4.33% |
| 2013 FY | 2.1 Billion USD | 58.82% |
| 2013 Q4 | 459.51 Million USD | -14.33% |
| 2013 Q3 | 536.4 Million USD | 34.11% |
| 2013 Q2 | 399.95 Million USD | -44.31% |
| 2013 Q1 | 718.15 Million USD | 81.77% |
| 2012 Q3 | 281.18 Million USD | -3.57% |
| 2012 Q1 | 285.38 Million USD | -10.34% |
| 2012 Q2 | 291.61 Million USD | 2.18% |
| 2012 Q4 | 395.09 Million USD | 40.51% |
| 2012 FY | 1.32 Billion USD | 38.72% |
| 2011 Q2 | 299.26 Million USD | 17.63% |
| 2011 Q4 | 318.29 Million USD | 6.27% |
| 2011 FY | 956.42 Million USD | -1.97% |
| 2011 Q1 | 254.4 Million USD | -1.77% |
| 2011 Q3 | 299.51 Million USD | 0.09% |
| 2010 FY | 975.62 Million USD | 6.06% |
| 2010 Q4 | 259 Million USD | 4.15% |
| 2010 Q3 | 248.67 Million USD | 6.28% |
| 2010 Q2 | 233.99 Million USD | -0.98% |
| 2010 Q1 | 236.3 Million USD | 0.79% |
| 2009 FY | 919.86 Million USD | 0.21% |
| 2009 Q4 | 234.44 Million USD | 0.6% |
| 2009 Q3 | 233.05 Million USD | 0.8% |
| 2009 Q2 | 231.2 Million USD | 4.55% |
| 2009 Q1 | 221.15 Million USD | -7.11% |
| 2008 Q2 | 228.46 Million USD | 4.9% |
| 2008 Q1 | 217.78 Million USD | -6.17% |
| 2008 FY | 917.92 Million USD | 13.1% |
| 2008 Q4 | 238.06 Million USD | 1.91% |
| 2008 Q3 | 233.6 Million USD | 2.25% |
| 2007 Q1 | 203.26 Million USD | -3.92% |
| 2007 Q4 | 232.1 Million USD | 7.59% |
| 2007 Q3 | 215.72 Million USD | 34.4% |
| 2007 Q2 | 160.5 Million USD | -21.04% |
| 2007 FY | 811.59 Million USD | 8.09% |
| 2006 FY | 750.87 Million USD | 58.65% |
| 2006 Q4 | 211.55 Million USD | 29.87% |
| 2006 Q3 | 162.89 Million USD | -15.64% |
| 2006 Q2 | 193.09 Million USD | 5.32% |
| 2006 Q1 | 183.34 Million USD | 8.21% |
| 2005 Q2 | 103.37 Million USD | 9.96% |
| 2005 FY | 473.3 Million USD | 41.96% |
| 2005 Q4 | 169.42 Million USD | 59.1% |
| 2005 Q3 | 106.48 Million USD | 3.01% |
| 2005 Q1 | 94.01 Million USD | 3.04% |
| 2004 FY | 333.4 Million USD | 8.48% |
| 2004 Q4 | 91.23 Million USD | 4.91% |
| 2004 Q3 | 86.97 Million USD | 8.68% |
| 2004 Q2 | 80.02 Million USD | 6.46% |
| 2004 Q1 | 75.16 Million USD | -26.51% |
| 2003 Q3 | 70.17 Million USD | -1.3% |
| 2003 Q2 | 71.09 Million USD | 11.5% |
| 2003 FY | 307.32 Million USD | 25.13% |
| 2003 Q1 | 63.76 Million USD | -3.18% |
| 2003 Q4 | 102.29 Million USD | 45.76% |
| 2002 Q2 | 61.21 Million USD | 109.37% |
| 2002 Q1 | -653.15 Million USD | -1127.78% |
| 2002 Q3 | 61.43 Million USD | 0.36% |
| 2002 FY | 245.61 Million USD | 5.82% |
| 2002 Q4 | 65.85 Million USD | 7.2% |
| 2001 Q3 | 60.12 Million USD | 2.48% |
| 2001 FY | 232.1 Million USD | -15.56% |
| 2001 Q1 | 49.77 Million USD | -22.89% |
| 2001 Q4 | 63.55 Million USD | 5.71% |
| 2001 Q2 | 58.66 Million USD | 17.85% |
| 2000 Q4 | 64.54 Million USD | 1.02% |
| 2000 Q1 | 72.49 Million USD | -49.26% |
| 2000 Q3 | 63.89 Million USD | -13.58% |
| 2000 FY | 274.87 Million USD | -26.95% |
| 2000 Q2 | 73.93 Million USD | 1.98% |
| 1999 Q2 | 93.6 Million USD | 55.48% |
| 1999 FY | 376.28 Million USD | 77.33% |
| 1999 Q1 | 60.2 Million USD | -20.37% |
| 1999 Q4 | 142.88 Million USD | 79.73% |
| 1999 Q3 | 79.5 Million USD | -15.06% |
| 1998 Q1 | 42.7 Million USD | 117.86% |
| 1998 FY | 212.2 Million USD | 222.49% |
| 1998 Q4 | 75.6 Million USD | 55.56% |
| 1998 Q3 | 48.6 Million USD | 7.28% |
| 1998 Q2 | 45.3 Million USD | 6.09% |
| 1997 FY | 65.8 Million USD | 63.68% |
| 1997 Q3 | 17.1 Million USD | 8.92% |
| 1997 Q2 | 15.7 Million USD | 20.77% |
| 1997 Q1 | 13 Million USD | 4.84% |
| 1997 Q4 | 19.6 Million USD | 14.62% |
| 1996 Q1 | 7.4 Million USD | 21.31% |
| 1996 Q2 | 9.7 Million USD | 31.08% |
| 1996 Q3 | 10.7 Million USD | 10.31% |
| 1996 Q4 | 12.4 Million USD | 15.89% |
| 1996 FY | 40.2 Million USD | 191.3% |
| 1995 Q4 | 6.1 Million USD | 10.91% |
| 1995 Q3 | 5.5 Million USD | 106.72% |
| 1995 FY | 13.8 Million USD | -14.81% |
| 1995 Q2 | -81.8 Million USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 FY | 16.2 Million USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -298.545% |
| Accuray Incorporated | 142.61 Million USD | -933.526% |
| Align Technology, Inc. | 2.07 Billion USD | 29.027% |
| Elevance Health Inc. | 36.23 Billion USD | 95.932% |
| AxoGen, Inc. | 149.33 Million USD | -887.025% |
| Boston Scientific Corporation | 7.5 Billion USD | 80.363% |
| CVS Health Corporation | 40.68 Billion USD | 96.377% |
| Cardinal Health, Inc. | 5 Billion USD | 70.52% |
| Centene Corporation | 138.33 Billion USD | 98.934% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 96.756% |
| Hologic, Inc. | 1.26 Billion USD | -16.281% |
| Humana Inc. | 102.36 Billion USD | 98.56% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -34.876% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | 27.081% |
| Masimo Corporation | 867 Million USD | -70.01% |
| McKesson Corporation | 8.67 Billion USD | 83.009% |
| Patterson Companies, Inc. | 1.12 Billion USD | -30.751% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | 8.448% |
| ResMed Inc. | 1.36 Billion USD | -7.718% |
| Henry Schein, Inc. | 2.93 Billion USD | 49.813% |
| Teladoc Health, Inc. | 2.09 Billion USD | 29.506% |
| Universal Health Services, Inc. | 9.2 Billion USD | 83.993% |
| Veeva Systems Inc. | 1.25 Billion USD | -17.258% |
| Baxter International Inc. | 5.27 Billion USD | 72.041% |
| Becton, Dickinson and Company | 6.71 Billion USD | 78.04% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 50.249% |
| Danaher Corporation | 8.75 Billion USD | 83.164% |
| Stryker Corporation | 9.2 Billion USD | 83.994% |
| Medtronic plc | 16.12 Billion USD | 90.861% |